Cargando…
Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration
Peroxisome proliferator-activated receptors (PPARs) activity has significant implications for the development of novel therapeutic modalities against neurodegenerative diseases. Although PPAR-α, PPAR-β/δ, and PPAR-γ nuclear receptor expressions are significantly reported in the brain, their implicat...
Autores principales: | Durai, Priya, Beeraka, Narasimha M., Ramachandrappa, Hemanth Vikram Poola, Krishnan, Prakash, Gudur, Pranesh, Raghavendra, Nulgumnalli Manjunathaiah, Ravanappa, Prashantha Kumar Bommenahally |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881103/ https://www.ncbi.nlm.nih.gov/pubmed/34751120 http://dx.doi.org/10.2174/1570159X19666211109141330 |
Ejemplares similares
-
Design and Development
of Novel Glitazones for Activation
of PGC-1α Signaling Via PPAR-γ Agonism: A Promising
Therapeutic Approach against Parkinson’s Disease
por: Prabhakaran, Prabitha, et al.
Publicado: (2023) -
Novel glitazones as PPARγ agonists: molecular design, synthesis, glucose uptake activity and 3D QSAR studies
por: Mandal, Subhankar P., et al.
Publicado: (2018) -
Are the adverse effects of glitazones linked to induced testosterone deficiency?
por: Carruthers, M, et al.
Publicado: (2008) -
Pleiotropic Effects of Glitazones: A Double Edge Sword?
por: Salomone, Salvatore
Publicado: (2011) -
Glitazone use associated with reduced risk of Parkinson's disease
por: Brakedal, Brage, et al.
Publicado: (2017)